Cardiovascular Disease

DOACs Increase Bleeding Risk More Than Warfarin in CKD

DOACs Increase Bleeding Risk More Than Warfarin in CKD

By

DOAC users with eGFRs less than 60 mL/min/1.73m2 had a 23% higher risk for bleeding than warfarin users.

USPSTF: Evidence Lacking for Nontraditional CVD Risk Factors

USPSTF: Evidence Lacking for Nontraditional CVD Risk Factors

Insufficient evidence for adding to traditional CVD risk assessment in asymptomatic adults.

Marriage May Protect Against Cardiovascular Disease

Marriage May Protect Against Cardiovascular Disease

Association seen between marital status and risk, prognosis of coronary heart disease or stroke

Apixaban May Reduce Major Bleeding Risk in Dialysis Patients With AFib

Apixaban May Reduce Major Bleeding Risk in Dialysis Patients With AFib

By

Apixaban recipients had a 28% lower risk for major bleeding compared with patients treated with warfarin.

Half of CV Events Occur from 2 to 5 Years Post-TIA, -Stroke

Half of CV Events Occur from 2 to 5 Years Post-TIA, -Stroke

Composite outcome occurred in 12.9%; 50.1% of events in second to fifth years.

Risk of CV Events Down With Med Diet Plus Olive Oil, Nuts

Risk of CV Events Down With Med Diet Plus Olive Oil, Nuts

Lower incidence of major cardiovascular events with Mediterranean diet supplemented with oil, nuts.

USPSTF: No to ECG Screening to Prevent CVD in Low-Risk Adults

USPSTF: No to ECG Screening to Prevent CVD in Low-Risk Adults

And evidence insufficient to recommend ECG screen for asymptomatic adults at intermediate or high risk.

Some Evidence Mobile Health Interventions Can Lower CVD Risk

Some Evidence Mobile Health Interventions Can Lower CVD Risk

mHealth programs generally improve overall cardiovascular disease risk, at least in the short term.

Erectile Dysfunction Strongly Predicts Cardiovascular Events

Erectile Dysfunction Strongly Predicts Cardiovascular Events

By

Men with erectile dysfunction (ED) are almost twice as likely to experience a cardiovascular event as those without ED.

No Consistent Cardiovascular Benefit Seen for Supplements

No Consistent Cardiovascular Benefit Seen for Supplements

Generally moderate- or low-quality evidence for preventive benefits, no effect, or increased risk

At Low Temps, Air Pollution May Up Risk of Sudden Cardiac Death

At Low Temps, Air Pollution May Up Risk of Sudden Cardiac Death

Particulate matter less than 2.5 m in diameter linked to higher sudden cardiac death risk in women

High Incidence of Sudden and/or Arrhythmic Death in CHD

High Incidence of Sudden and/or Arrhythmic Death in CHD

SAD cause of considerable proportion of deaths in CHD patients without severe systolic dysfunction

Metabolically Healthy Obesity Not Without Risk of CVD

Metabolically Healthy Obesity Not Without Risk of CVD

Findings show MHO is transient, so not a reliable predictor of lower cardiovascular risk in the future

Aortic Stiffness, Concentric LV Remodeling Linked in T2DM

Aortic Stiffness, Concentric LV Remodeling Linked in T2DM

Aortic distensibility independently linked to concentric left ventricular remodeling

High FGF-23 Linked to Recurrent Cardiac Events After ACS

High FGF-23 Linked to Recurrent Cardiac Events After ACS

FGF-23 in top quartile independently linked to greater risk of CV death, heart failure hospitalization.

No Reduced CVD Risk for SBP <120 mm Hg in Type 2 Diabetes

No Reduced CVD Risk for SBP <120 mm Hg in Type 2 Diabetes

Increased risk of CVD for achieved systolic blood pressure of 120 versus 130 or 140 mm Hg

Predialysis Nephrology Care Associated With Lower AFib Risk

Predialysis Nephrology Care Associated With Lower AFib Risk

By

Older patients who had more frequent nephrology visits prior to initiating dialysis had a lower incidence of atrial fibrillation in the year after initiating dialysis compared with those who did not.

Exercise Best Defense for Those at Genetic Risk for CVD

Exercise Best Defense for Those at Genetic Risk for CVD

Benefit of exercise against cardiovascular disease notable even among those at high genetic risk

Lonely Individuals May Have Increased Risk for AMI, Stroke

Lonely Individuals May Have Increased Risk for AMI, Stroke

Social isolation linked to increased mortality among individuals with history of AMI or stroke

Lead Exposure May Increase Risk for Cardiovascular Disease Mortality

Lead Exposure May Increase Risk for Cardiovascular Disease Mortality

Environmental lead exposure tied to all-cause, cardiovascular disease, ischemic heart disease mortality.

Exercise, Not Weight Loss, Linked to Lower Death Risk in CHD

Exercise, Not Weight Loss, Linked to Lower Death Risk in CHD

But no mortality risk reduction associated with weight loss in individuals with coronary heart disease

Generic Clopidogrel on Par With Plavix in Acute Coronary Syndrome

Generic Clopidogrel on Par With Plavix in Acute Coronary Syndrome

Clopidogrel noninferior for patients older than 65 years after acute coronary syndrome hospitalization.

FGF23 Tied to Coronary Heart Disease

FGF23 Tied to Coronary Heart Disease

After adjustment for hormone therapy use in women, associations no longer differed by sex

Mortality Risks Higher With Febuxostat vs Allopurinol

Mortality Risks Higher With Febuxostat vs Allopurinol

By

All-cause and cardiovascular mortality risks were 22% and 34% higher among febuxostat-treated patients vs allopurinol recipients.

Urgency Urinary Incontinence Linked to Previous Stroke

Urgency Urinary Incontinence Linked to Previous Stroke

By

Individuals who had a stroke or transient ischemic attack at age 60 to 64 had a 2-fold higher risk of UUI at age 68 years, a British study found.

Women With Ischemia, Non-Obstructive CAD May Have Myocardial Scars

Women With Ischemia, Non-Obstructive CAD May Have Myocardial Scars

Cardiac MR accurately diagnoses; myocardial scars may affect 8% of women with non-obstructive CAD

Readmission Rates High for HD Patients After CVD Hospitalization

Readmission Rates High for HD Patients After CVD Hospitalization

By

In a study, the 30-day readmission rate for hemodialysis patients hospitalized for cardiovascular events was 34.2%.

Testosterone Replacement Therapy Does Not Raise CV Risks

Testosterone Replacement Therapy Does Not Raise CV Risks

By

A large study of middle-aged men found that testosterone replacement therapy is associated with a small but significant decrease in cardiovascular risk and an increased risk of obstructive sleep apnea.

Vitamin D Supplementation Improves Endothelial Dysfunction in CKD

Vitamin D Supplementation Improves Endothelial Dysfunction in CKD

By

Vitamin D levels increased from 13.2 to 33.7 ng/mL in nondialysis CKD patients treated with 50,000 units of cholecalciferol weekly for 12 weeks.

Clarithromycin May Damage Heart, FDA Warns

Clarithromycin May Damage Heart, FDA Warns

Agency advising doctors to consider prescribing other antibiotics to patients with coronary heart disease

Sign Up for Free e-newsletters